3 results match your criteria: "Henan Provincial Chest Hospital Affiliated to Zhengzhou University[Affiliation]"
J Infect
December 2024
Department of Infectious Diseases, State Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. Electronic address:
Objectives: Azvudine has been designated as a priority treatment for patients infected with SARS-CoV-2, however, clinical evidence in hospitalized cases remains insufficient.
Methods: We performed a multi-center, retrospective cohort study to evaluate the effectiveness and safety of azvudine in hospitalized patients with SARS-CoV-2 in China (NCT06349655). Kaplan-Meier method, Cox regression model, subgroup analysis, and seven sensitive analyses were employed.
Mikrochim Acta
April 2024
Department of Thoracic Surgery, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China.
Isoniazid and streptomycin are vital drugs for treating tuberculosis, which are utilized as efficient anti-tuberculosis agents. This paper presents a novel visible-light-driven composite photocatalyst TiC/Bi/BiOI, which was built from TiC nanosheets and Bi/BiOI microspheres. Photoelectrochemical (PEC) sensors based on TiC/Bi/BiOI were synthesized for isoniazid identification, which showed a linear concentration range of 0.
View Article and Find Full Text PDFClin Exp Hypertens
December 2023
Department of Cardiology, Henan Provincial Chest Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, P.R. China.
Objective: Neointimal hyperplasia is the primary mechanism underlying atherosclerosis and restenosis after percutaneous coronary intervention. Ketogenic diet (KD) exerts beneficial effects in various diseases, but whether it could serve as non-drug therapy for neointimal hyperplasia remains unknown. This study aimed to investigate the effect of KD on neointimal hyperplasia and the potential mechanisms.
View Article and Find Full Text PDF